SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-000401
Filing Date
2022-01-19
Accepted
2022-01-19 16:19:00
Documents
15
Period of Report
2022-01-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20220113.htm   iXBRL 8-K 54766
2 EX-10.1 crbu-ex10_1.htm EX-10.1 1013106
3 GRAPHIC img107092706_0.jpg GRAPHIC 81926
4 GRAPHIC img107092706_1.jpg GRAPHIC 111064
  Complete submission text file 0000950170-22-000401.txt   1589905

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20220113_lab.xml EX-101.LAB 13438
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20220113.xsd EX-101.SCH 2489
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20220113_pre.xml EX-101.PRE 9932
9 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20220113_htm.xml XML 4715
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 22539009
SIC: 2836 Biological Products, (No Diagnostic Substances)